Amanote Research
Register
Sign In
477. Phase I Safety and Immunogenicity of HPV 16 and 18 DNA Vaccines Delivered via Electroporation
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)37918-7
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2010
Authors
Unknown
Publisher
Elsevier BV
Related search
The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Efficacy, Immunogenicity and Safety of the AS04‐HPV‐16/18 Vaccine in Chinese Women Aged 18‐25 Years: End‐of‐study Results From a Phase II/III, Randomised, Controlled Trial
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Therapeutic HPV DNA Vaccines
Expert Review of Vaccines
Molecular Medicine
Drug Discovery
Immunology
Pharmacology
Clinical Significance of an HPV DNA Chip Test With Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART
Frontiers in Immunology
Allergy
Immunology
PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Safety and Immunogenicity of the DTP/HB /Hib Combination Vaccine: Phase I Study
Paediatrica Indonesiana
Comparison of the Immunogenicity and Safety of Two 17D Yellow Fever Vaccines.
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Lack of HPV 16 and 18 Detection in Serum of Colposcopy Clinic Patients
Journal of Clinical Virology
Virology
Infectious Diseases
